AEM vs MLM

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

MLM exhibits a stable but mediocre financial health profile with a Piotroski F-Score of 4/9 and no available Altman Z-Score. The stock is severely overvalued, trading at $612.85, which is more than double its Graham Number ($247.45) and over five times its growth-based intrinsic value ($114.52). While revenue shows modest growth, earnings are trending downward both YoY (-4.10%) and Q/Q (-5.10%), creating a dangerous disconnect between price and fundamental performance. The bearish technical trend (0/100) further suggests a lack of market momentum to support these premium valuations.